Armando Ramirez։ Key Takeaways from NLA’s Updated Clinical Guidance on Familial Hypercholesterolemia
Armando Ramirez, US Sales and Business Development Director at GENinCode Predictive Genetics, shared a National Lipid Association post on LinkedIn, adding:
”This is huge…
Here are some of my takeaways:
- Earlier identification through universal pediatric screening, opportunistic adult screening, and systematic cascade testing of families – this is a positive step forward.
- Genetic testing as a powerful complement to clinical diagnosis and family screening (not a barrier to treatment) – as a speciality, we need to be screening more.
- More aggressive LDL-C targets (often <70 mg/dL for primary prevention, <55 mg/dL for secondary prevention) – this will lead to better outcomes.
FH is one of the most preventable causes of premature heart disease. I feel this update moves us closer to proactive, precision-driven, family-centered prevention.”
Quoting National Lipid Association՛s post:
”NOW AVAILABLE: The NLA’s Updated Clinical Guidance on Familial Hypercholesterolemia (FH)
This updated expert clinical consensus on FH reflects more than a decade of advances in screening, diagnosis, and treatment.
- Read the full consensus statement.
- Watch our CME-accredited video podcast with key authors.
- View the press release․
Title: Update on familial hypercholesterolemia: an expert clinical consensus from the National Lipid Association
Authors: Zahid Ahmad, Anandita Agarwala, Marina Cuchel, P. Barton Duell, Robert A. Hegele, Lisa Hudgins, Allison Jamison, Dinesh Kalra, Amit Khera, Joshua W. Knowles, Iftikhar Kullo, Ana Morales, Mark A. Rothstein, Joseph J. Saseen, Daniel Soffer, Bruce A. Warden, William S. Weintraub, Lauren Williams, Anne C. Goldberg
Read the Full Article on Journal of Clinical Lipidology.

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 04:31Aakriti Gupta: Anticoagulation for Leaflet Thickening After TAVR
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis
-
Nov 14, 2026, 23:46Habib Bennaceur: Moving Towards Fewer Limitations for People Living With Haemophilia
-
Nov 14, 2026, 23:44Paul Healy: EU Approves Frehemgo for Haemophilia A
-
Nov 14, 2026, 23:43Mehak Trehan: ASH 2026 Benign Hematology – Ten Abstracts Through an Indian Lens
-
Nov 14, 2026, 23:33Felipe Magalhaes Furtado: Artificial Intelligence Advances PNH Clone Detection Through Machine Learning
-
Nov 14, 2026, 23:33Mona Alfaraj: International Pathology Day Promotes Education in Hemoglobinopathy Diagnostics